MERCK KGAA NAM.SP.ADR (MRKC) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.045x

Based on the latest financial reports, MERCK KGAA NAM.SP.ADR (MRKC) has a cash flow conversion efficiency ratio of 0.045x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.29 Billion ≈ $1.51 Billion USD) by net assets (€28.66 Billion ≈ $33.51 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MRKC days of operational coverage to measure how many days the company can operate on defensive assets alone.

MERCK KGAA NAM.SP.ADR - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how MERCK KGAA NAM.SP.ADR's cash flow conversion efficiency has evolved over time, based on yearly financial data.

MERCK KGAA NAM.SP.ADR Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MERCK KGAA NAM.SP.ADR ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Tourmaline Oil Corp.
TO:TOU
0.059x
Bank of Hangzhou Co Ltd
SHG:600926
-0.217x
Falabella
SN:FALABELLA
0.018x
Lenovo Group Limited
F:LHL1
0.073x
mBank SA
WAR:MBK
-0.739x
Rongsheng Petrochemical Co Ltd
SHE:002493
0.167x
China Shipbuilding Industry Co Ltd
SHG:601989
-0.021x
Telkom Indonesia (Persero) Tbk PT
JK:TLKM
0.110x

Annual Cash Flow Conversion Efficiency for MERCK KGAA NAM.SP.ADR (2020–2025)

The table below shows the annual cash flow conversion efficiency of MERCK KGAA NAM.SP.ADR from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see MRKC market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €28.66 Billion
≈ $33.51 Billion
€3.93 Billion
≈ $4.60 Billion
0.137x -10.29%
2024-12-31 €29.99 Billion
≈ $35.06 Billion
€4.59 Billion
≈ $5.36 Billion
0.153x +8.13%
2023-12-31 €26.75 Billion
≈ $31.28 Billion
€3.78 Billion
≈ $4.42 Billion
0.141x -13.64%
2022-12-31 €26.00 Billion
≈ $30.40 Billion
€4.26 Billion
≈ $4.98 Billion
0.164x -24.02%
2021-12-31 €21.42 Billion
≈ $25.04 Billion
€4.62 Billion
≈ $5.40 Billion
0.216x +5.49%
2020-12-31 €17.02 Billion
≈ $19.89 Billion
€3.48 Billion
≈ $4.06 Billion
0.204x --

About MERCK KGAA NAM.SP.ADR

F:MRKC Germany Drug Manufacturers - Specialty & Generic
Market Cap
$17.07 Billion
€14.60 Billion EUR
Market Cap Rank
#1488 Global
#327 in Germany
Share Price
€22.60
Change (1 day)
-2.59%
52-Week Range
€20.20 - €26.20
All Time High
€44.30
About

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more